Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination.

Warpechowski, Jedrzej; Leszczynska, Paula; Juchnicka, Dominika; Olichwier, Adam; Szczerbinski, Lukasz; Kretowski, Adam Jacek

Warpechowski, Jedrzej; Leszczynska, Paula; Juchnicka, Dominika; Olichwier, Adam; Szczerbinski, Lukasz; Kretowski, Adam Jacek.

Afiliación

Warpechowski J; Clinical Research Centre, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Leszczynska P; Clinical Research Centre, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Juchnicka D; Clinical Research Centre, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Olichwier A; Clinical Research Centre, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.
Szczerbinski L; Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE 68588, USA.
Kretowski AJ; Clinical Research Centre, Medical University of Bialystok, Sklodowskiej-Curie 24A, 15-276 Bialystok, Poland.

Vaccines (Basel) ; 11(7)2023 Jul 05.

Article en En | MEDLINE | ID: mdl-37515018

Palabras clave

2019-nCoV vaccine mRNA-1273; Ad26COVS1; BNT 162 vaccine; ChAdOx1 nCoV-19; SARS-CoV-2; diabetes mellitus type 1; diabetes mellitus type 2; immunogenicity; obesity; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google